Yanfang Wei

Liver cancer stem cells drive hepatocellular carcinoma progression and therapeutic resistance

Hepatocellular carcinoma (HCC) is a highly prevalent and lethal malignancy worldwide, with persistently high rates of therapeutic resistance and post-treatment recurrence. Liver cancer stem cells (LCSCs), a distinct subpopulation of cancer cells endowed with stem cell-like proper...